{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:05:52Z","timestamp":1780491952345,"version":"3.54.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) has become a major global public health challenge, affecting more than 500 million adults worldwide. Early vascular aging (EVA) is one of the key pathological changes for diabetic vascular complications. However, targeted and effective therapeutic strategies remain limited. Based on our previous research and clinical experience, we developed a granulated natural herbal formulation, Yiqi-Yangyin-Huoxue (YQYYHX). This trial aims to evaluate the clinical efficacy and safety of YQYYHX in patients with T2DM and EVA, and to preliminarily explore its potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single-center, randomized, double-blind, placebo-controlled, parallel-group clinical trial. It will enroll 120 participants with T2DM and EVA, who will be randomized in a 1:1 allocation ratio to two groups. In addition to standard therapy, the treatment group will receive the YQYYHX granules, while the control group will receive a matched placebo. Based on mass spectrometry analysis, daidzin, salvianolic acid L, and oleamide were identified as the compounds with the largest peak area in YQYYHX. After a 12-week intervention, brachial-ankle pulse wave velocity (baPWV) is planned to be assessed as the primary outcome. Secondary outcomes are expected to include the ankle-brachial index, blood glucose levels, lipid profiles, inflammatory cytokines, 6-min walk test and questionnaires. Safety will be evaluated using liver transaminases, serum creatinine, and related indicators. Serum and fecal samples will be collected before and after treatment. The serum will be used for metabolomic and proteomic sequencing analysis, and feces will be used for metagenomic sequencing. Electronic case report forms are generated within the clinical record system, ensuring that all follow-up information is traceable. Subsequently, the data will be entered into a specific electronic data capture, and the data administrator will verify it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The recruitment began on March 27, 2025 and is expected to end on December 31, 2026. As of March 10, 2026, 72 participants have been enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This rigorously designed trial is expected to generate reliable evidence. As a complementary and alternative therapeutic option, YQYYHX has the potential to benefit patients with T2DM and EVA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      This trial has been registered with the International Traditional Medicine Clinical Trial Registry Platform (\n                      <jats:ext-link>http:\/\/itmctr.ccebtcm.org.cn\/<\/jats:ext-link>\n                      , ITMCTR2024000388).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1768610","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:17:48Z","timestamp":1780489068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol"],"prefix":"10.3389","volume":"13","author":[{"given":"Jinyi","family":"Fu","sequence":"first","affiliation":[{"name":"Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Qi","sequence":"additional","affiliation":[{"name":"Beijing Tsinghua Changgung Hospital, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhan","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Su","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucong","family":"Gao","sequence":"additional","affiliation":[{"name":"Qi-Huang College, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"Key Laboratory for Preventing Vascular Aging by Combination of Disease and Syndrome, National Administration of Traditional Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","year":"2025","journal-title":"IDF Diabetes Atlas, 11th edn"},{"key":"B2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","author":"GBD","year":"2023","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1016\/S2468-2667(24)00250-0","article-title":"Diabetes in China part 1: epidemiology and risk factors","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e14487","DOI":"10.1111\/dme.14487","article-title":"Trends in prevalence and incidence of type 2 diabetes among adults in Beijing, China, from 2008 to 2017","volume":"38","author":"Wang","year":"2021","journal-title":"Diabet Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e032626","DOI":"10.1161\/JAHA.123.032626","article-title":"Diabetes-related macrovascular complications are associated with an increased risk of diabetic microvascular complications: a prospective study of 1,518 patients with type 1 diabetes and 20,802 patients with type 2 diabetes in the UK Biobank","volume":"13","author":"Zhang","year":"2024","journal-title":"J Am Heart Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1541259","DOI":"10.3389\/fmed.2025.1541259","article-title":"Risk prediction model of early vascular aging based on nomogram in patients with type 2 diabetes mellitus: a cross-sectional study in a Chinese population","volume":"12","author":"Zhao","year":"2025","journal-title":"Front Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdiacomp.2017.10.003","article-title":"Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study","volume":"32","author":"Zhang","year":"2018","journal-title":"J Diabetes Complications."},{"key":"B9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1753-0407.2011.00171.x","article-title":"Prevalence of and risk factors for abnormal ankle-brachial index in patients with type 2 diabetes","volume":"4","author":"Li","year":"2012","journal-title":"J Diabetes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.diabres.2010.09.009","article-title":"Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus","volume":"91","author":"Rhee","year":"2011","journal-title":"Diabetes Res Clin Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2147\/CIA.S423373","article-title":"Vascular aging: assessment and intervention","volume":"18","author":"Li","year":"2023","journal-title":"Clin Interv Aging."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2022.21243","article-title":"Guidelines for reporting outcomes in trial protocols: the spirit-outcomes 2022 extension","volume":"328","author":"Butcher","year":"2022","journal-title":"JAMA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11655-018-2999-x","article-title":"Standard protocol items for clinical trials with traditional Chinese medicine 2018: recommendations, explanation and elaboration (SPIRIT-TCM extension 2018)","volume":"25","author":"Dai","year":"2019","journal-title":"Chin J Integr Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1004589","DOI":"10.1371\/journal.pmed.1004589","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"22","author":"Chan","year":"2025","journal-title":"PLoS Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement","volume":"326","author":"US Preventive Services Task","year":"2021","journal-title":"JAMA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/agm2.12049","article-title":"Cardiovascular group, society of geriatrics, Chinese medical association. expert consensus on clinical assessment and intervention of vascular aging in China","volume":"1","author":"Zhang","year":"2018","journal-title":"Aging Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1573402113666170413094319","article-title":"Early vascular ageing (EVA): definitions and clinical applicability","volume":"13","author":"Cunha","year":"2017","journal-title":"Curr Hypertens Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's choice \u2013 European society for vascular surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"ATS","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13098-023-01108-8","article-title":"Trajectories of glycated hemoglobin of T2DM and progress of arterial stiffness: a prospective study","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12902-023-01355-w","article-title":"Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus","volume":"23","author":"Pei","year":"2023","journal-title":"BMC Endocr Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1291\/hypres.26.807","article-title":"Brachial-ankle pulse wave velocity is useful for evaluation of complications in type 2 diabetic patients","volume":"26","author":"Aso","year":"2003","journal-title":"Hypertens Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0171737","DOI":"10.1371\/journal.pone.0171737","article-title":"Reference values of Brachial-ankle pulse wave velocity according to age and blood pressure in a central Asia population","volume":"12","author":"Yiming","year":"2017","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1161\/HYPERTENSIONAHA.123.22436","article-title":"Influence of blood pressure reduction on pulse wave velocity in primary hypertension: a meta-analysis and comparison with an acute modulation of transmural pressure","volume":"81","author":"McNally","year":"2024","journal-title":"Hypertension."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","article-title":"Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy","volume":"114","author":"M\u00e4ki-Pet\u00e4j\u00e4","year":"2006","journal-title":"Circulation."},{"key":"B27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/jcdd10020044","article-title":"What is the smallest change in pulse wave velocity measurements that can be attributed to clinical changes in arterial stiffness with certainty: a randomized cross-over study","volume":"10","author":"Podrug","year":"2023","journal-title":"J Cardiovasc Dev Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.2337\/dc25-S013","article-title":"13. older adults: standards of care in diabetes-2025","volume":"48","author":"American","year":"2025","journal-title":"Diabetes Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/JIR.S335374","article-title":"Hypermethylation effects of Yiqihuoxue decoction in diabetic atherosclerosis using genome-wide dna methylation analyses","volume":"15","author":"Zhou","year":"2022","journal-title":"J Inflamm Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11655-015-2298-8","article-title":"Protective effects of Xiongshao Capsule () on anti-inflammatory function of high-density lipoprotein in an atherosclerosis rabbit model","volume":"23","author":"Zhang","year":"2017","journal-title":"Chin J Integr Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e034126","DOI":"10.1161\/JAHA.123.034126","article-title":"Urinary equol and equol-predicting microbial species are favorably associated with cardiometabolic risk markers in Chinese adults","volume":"13","author":"Liang","year":"2024","journal-title":"J Am Heart Assoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-022-01696-1","article-title":"Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes","volume":"21","author":"Wu","year":"2022","journal-title":"Cardiovasc Diabetol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.3390\/jcm13195713","article-title":"The importance of orthostatic increase in pulse wave velocity in the diagnosis of early vascular aging","volume":"13","author":"Dorogovtsev","year":"2024","journal-title":"J Clin Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41440-025-02281-1","article-title":"Comparison between vascular age based on brachial-ankle pulse wave velocity or carotid-femoral pulse wave velocity","volume":"48","author":"Dong","year":"2025","journal-title":"Hypertens Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-019-0915-0","article-title":"Positive association between baseline brachial-ankle pulse wave velocity and the risk of new-onset diabetes in hypertensive patients","volume":"18","author":"Zhang","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jch.14548","article-title":"The positive correlation between brachial-ankle pulse wave velocity and aortic diameter in Chinese patients with diabetes","volume":"24","author":"Li","year":"2022","journal-title":"J Clin Hypertens."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1161\/HYPERTENSIONAHA.123.21314","article-title":"Reimagining the value of brachial-ankle pulse wave velocity as a biomarker of cardiovascular disease risk-a call to action on behalf of vascagenet","volume":"80","author":"Stone","year":"2023","journal-title":"Hypertension."},{"key":"B39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3803\/EnM.2018.33.1.88","article-title":"High brachial ankle pulse wave velocity as a marker for predicting coronary artery stenosis in patients with type 2 diabetes","volume":"33","author":"Kim","year":"2018","journal-title":"Endocrinol Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4093\/dmj.2012.36.6.443","article-title":"Relationships between brachial-ankle pulse wave velocity and peripheral neuropathy in type 2 diabetes","volume":"36","author":"Ha","year":"2012","journal-title":"Diabetes Metab J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e923112","DOI":"10.12659\/MSM.923112","article-title":"Determinants of brachial-ankle pulse wave velocity and vascular aging in healthy older subjects","volume":"26","author":"Sang","year":"2020","journal-title":"Med Sci Monit."},{"key":"B42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40520-014-0262-7","article-title":"Brachial-ankle pulse wave velocity is a predictor of walking distance in community-dwelling adults","volume":"27","author":"Kawamoto","year":"2015","journal-title":"Aging Clin Exp Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s11255-020-02404-2","article-title":"Brachial-ankle pulse wave velocity is independently associated with urine albumin-to-creatinine ratio in a Chinese community-based cohort","volume":"52","author":"Jiang","year":"2020","journal-title":"Int Urol Nephrol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e011650","DOI":"10.1161\/JAHA.118.011650","article-title":"Subclinical longitudinal change in ankle-brachial index with aging in a community-dwelling population is associated with central arterial stiffening","volume":"8","author":"Oberdier","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Ankle Brachial Index","year":"2008","journal-title":"JAMA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2016.11.023","article-title":"Ankle-brachial index and physical function in older individuals: the atherosclerosis risk in communities (ARIC) study","volume":"257","author":"Matsushita","year":"2017","journal-title":"Atherosclerosis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00125-011-2404-1","article-title":"Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds","volume":"55","author":"Zoungas","year":"2012","journal-title":"Diabetologia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1237282","DOI":"10.3389\/fendo.2023.1237282","article-title":"Association between blood glucose levels and arterial stiffness marker: comparing the second derivative of photoplethysmogram and cardio-ankle vascular index scores","volume":"14","author":"Park","year":"2023","journal-title":"Front Endocrinol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1277162","DOI":"10.3389\/fendo.2023.1277162","article-title":"Positive correlation between lipid accumulation product index and arterial stiffness in Chinese patients with type 2 diabetes","volume":"14","author":"Mao","year":"2023","journal-title":"Front Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12944-024-02183-0","article-title":"The roles of lipids and inflammation in the association between the triglyceride-glucose index and arterial stiffness: evidence from two large population-based surveys","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-021-01330-6","article-title":"Association of TyG index and TG\/HDL-C ratio with arterial stiffness progression in a non-normotensive population","volume":"20","author":"Wu","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/ijms23020963","article-title":"Inflammation as a precursor of atherothrombosis, diabetes and early vascular aging","volume":"23","author":"Barbu","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1136\/ard-2024-225630","article-title":"Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis","volume":"83","author":"Fang","year":"2024","journal-title":"Ann Rheum Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1470035","DOI":"10.3389\/fpubh.2024.1470035","article-title":"Long-term impact of diabetes prevention program interventions on walking endurance","volume":"12","author":"Munshi","year":"2024","journal-title":"Front Public Health."},{"key":"B56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ejvs.2021.10.031","article-title":"Vascular quality of life questionnaire-6 before and after supervised exercise therapy in patients with intermittent claudication","volume":"63","author":"Hageman","year":"2022","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12955-017-0760-3","article-title":"Validation of the vascular quality of life questionnaire - 6 for clinical use in patients with lower limb peripheral arterial disease","volume":"15","author":"Larsen","year":"2017","journal-title":"Health Qual Life Outcomes."},{"key":"B58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000526345","article-title":"The relationship between vascular aging phenotypes and renal damage among individuals with type 2 diabetes","volume":"13","author":"Li","year":"2023","journal-title":"Cardiorenal Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2020.07.020","article-title":"Evidence-based research series-paper 1: what evidence-based research is and why is it important?","volume":"129","author":"Robinson","year":"2021","journal-title":"J Clin Epidemiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1768610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:17:49Z","timestamp":1780489069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1768610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":59,"alternative-id":["10.3389\/fmed.2026.1768610"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1768610","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1768610"}}